Drug profile · INN
gallium dotatate ga-68
NETSPOT
gallium dotatate ga-68 (NETSPOT) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — gallium dotatate ga-68
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
gallium dotatate ga-68 (NETSPOT) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN gallium dotatate ga-68
Brand NETSPOT
Mechanism Diagnostic
Route INTRAVENOUS
Formulation POWDER
Mechanism of action
Diagnostic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is gallium dotatate ga-68?
gallium dotatate ga-68 (NETSPOT) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gallium dotatate ga-68?
NETSPOT is a marketed brand name for gallium dotatate ga-68. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gallium dotatate ga-68?
gallium dotatate ga-68 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.